Latest News

Latest News

News from the World Hepatitis Alliance

Viral Hepatitis and the Sustainable Development Goals: driving action towards elimination

24 Feb 2016 Tara Farrell

Today, leading medical professionals, policymakers, civil society and patients gathered at a policy symposium organised by the Coalition to Eradicate...

World Hepatitis Day 2016 theme announced

23 Feb 2016 Bridie Taylor

With the first ever WHO Global Elimination Strategy on Viral Hepatitis set for its likely adoption at the World Health Assembly in May, 2016 will be...

Meeting an unmet need: the road from Alice Springs to Brazil

23 Feb 2016 Tara Farrell

Viral hepatitis is a major, devastating and under-recognised health issue within Indigenous communities worldwide, affecting thousands of people each...

Hepatitis C Elimination Manifesto to be launched in Brussels tomorrow

16 Feb 2016 Bridie Taylor

Tomorrow, George Kalamitsis, WHA Executive Board Member for the European Region and Charles Gore, WHA President, will join over 100 European and...

World Hepatitis Alliance seeks highly organised individual for Officer Manager vacancy

8 Feb 2016 Bridie Taylor

Make a positive change this year and join us in our fight to eliminate hepatitis. We are looking for experienced Office Manager to join our dynamic...

80% of liver cancer deaths can be prevented, saving hundreds of thousands of lives each year globally

4 Feb 2016 Tara Farrell

On World Cancer Day, the World Hepatitis Alliance is calling for the establishment of comprehensive hepatitis strategies to help prevent the 800,000...

World Hepatitis Alliance seeks motivated Project Assistant to help organise the World Hepatitis Summit

3 Feb 2016 Bridie Taylor

Make a positive change this year and join us in our fight to eliminate hepatitis. We are looking for an organised and motivated Project Assistant to...

A step towards the elimination of viral hepatitis

28 Jan 2016 Tara Farrell

Today, Member States and civil society groups convened at the World Health Organization (WHO) Executive Board (EB) meeting in Geneva to discuss the...

New addition to the WHA team

28 Jan 2016 Bridie Taylor

Preparations for the second World Hepatitis Summit (WHS2017), taking place in Brazil early 2017, are now underway and the World Hepatitis Alliance...

WHA presents Tools For Change webinar series to enhance patient advocacy

27 Jan 2016 Bridie Taylor

Patient group advocacy has the power to effect real lasting change and improve the lives of millions living with viral hepatitis. We believe that...

Welcoming five new members to the World Hepatitis Alliance

26 Jan 2016 Bridie Taylor

This month, we welcome five new organisations to the World Hepatitis Alliance. Our alliance is now made up of 230 organisations in 81 countries in...

Hepatitis Testing Innovation Contest now open for submissions!

19 Jan 2016 Tara Farrell

Do you have a new and exciting idea on how to deliver hepatitis B and C testing? Be in with a chance to contribute to the 2016 WHO Hepatitis Testing...

World Hepatitis Day 2015 Summary Report released

19 Jan 2016 Bridie Taylor

On 28 July, World Hepatitis Day (WHD) brings the world together to raise awareness of the global burden of viral hepatitis and to influence real...

Public health experts, patients and policymakers convene at inaugural African Viral Hepatitis Summit to discuss the need for comprehensive national plans

19 Jan 2016 Tara Farrell

Today, more than 100 leading African and international public health experts, patient representatives, policymakers and physicians have gathered in...

Patient Solidarity Day: Uniting to declare healthcare a human right

3 Dec 2015 Bridie Taylor

On 5th December, patients across the globe will unite to mark Patient Solidarity Day and reaffirm that healthcare is a human right. Co-ordinated by...

Welcoming four new members

2 Dec 2015 Bridie Taylor

The World Hepatitis Alliance continues to grow as we welcome four new member organisations. Our membership is now made up of over 225 groups in 81...

HIV patients with viral hepatitis are three times more likely to have liver disease, liver failure and liver-related deaths

1 Dec 2015 Bridie Taylor

On World AIDS Day, the World Hepatitis Alliance calls for increased recognition of viral hepatitis and HIV coinfections London, 1 December 2015 -...

Innovative patent agreement shows success of patient advocacy

23 Nov 2015 Bridie Taylor

The World Hepatitis Alliance congratulates the Medicines Patent Pool (MPP) and Bristol – Myers Squibb (BMS) for recognising the global hepatitis...

Medicines Patent Pool expands its mandate to hepatitis C treatment

6 Nov 2015 Bridie Taylor

The World Hepatitis Alliance welcomes the recent announcement from the Medicines Patent Pool (MPP) that they will be expanding their mandate to...

The global hepatitis community unites to demand access to life-saving hepatitis treatment

2 Nov 2015 Bridie Taylor

London, 2 November 2015: Today the World Hepatitis Alliance launches an open letter calling for immediate action to vastly improve access to life-...

Pages

News from infohep

Georgia: 98% cured of hepatitis C

23 May 2018 Keith Alcorn
Georgia is making strong progress towards eliminating hepatitis C but will need triple the number of people starting treatment if it is to reach its...

T cell immunotherapy shows promise for treating liver cancer

22 May 2018 Liz Highleyman
Personalised immunotherapy reduces the risk of liver cancer recurrence and may lead to tumour regression, according to a pair of studies presented at...

Do fatigue and quality of life improve after hepatitis C is cured?

15 May 2018 Keith Alcorn
Patient-reported outcomes such as fatigue, vitality and mental health improve substantially in the two years following hepatitis C cure for people...

Does portal hypertension always improve after hepatitis C cure?

10 May 2018 Keith Alcorn
Although portal hypertension improves in the majority of people with hepatitis C and cirrhosis after hepatitis C is cured, not all people experience...

Combining hepatitis C therapy and buprenorphine leads to good outcomes for people who inject drugs

8 May 2018 Liz Highleyman
Offering hepatitis C treatment and opioid substitution therapy with buprenorphine at the same location can help increase adherence and reduce harms...

Switching to TAF improves safety in people with hepatitis B with kidney and bone risk factors

4 May 2018 Liz Highleyman
People with risk factors for tenofovir toxicity who switched from tenofovir disoproxil fumarate (TDF; Viread) to the new tenofovir alafenamide (TAF;...

Fewer non-liver cancers in people treated with DAAs compared to the interferon era

2 May 2018 Keith Alcorn
The risk of non-liver cancer is lower in people treated with direct-acting antivirals (DAAs) than in those treated with interferon and is probably an...

Myrcludex B plus tenofovir suppresses hepatitis delta

30 Apr 2018 Liz Highleyman
An experimental drug that blocks the entry of hepatitis B virus (HBV) and hepatitis delta virus (HDV) into liver cells suppressed HBV and HDV levels...

Sustained virological response reduces risk of serious cardiovascular disease in people with HCV-related compensated cirrhosis

27 Apr 2018 Michael Carter
Successful hepatitis C virus (HCV) therapy reduces the risk of a serious cardiovascular event in people with compensated liver cirrhosis, French...

Local therapy with sorafenib does not improve liver cancer survival

23 Apr 2018 Liz Highleyman
Combining sorafenib (Nexavar) with internal radiation therapy or transarterial chemoembolization did not improve overall survival for people with...